Article

Sponsored Content

Cancer's R&D Convergence

Cancer's R&D Convergence will highlight the changing landscape for clinical trials in this therapeutic area based on the promise of the Cancer MoonShot initiative, along with new oncology immunotherapies.

 

 

External Link - ACT_Cancer-RD_Convergence.pdf

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
Related Content
© JHVEPhoto - © JHVEPhoto - stock.adobe.com
August 28th 2025

FDA Authorizes New COVID Vaccines with Restrictions on Eligibility

Davy James
ACT Brief Episode 6: Supreme Court Ruling, VK2735 Obesity Trial, and Padcev-Keytruda Survival Gains
August 28th 2025

ACT Brief Episode 6: Supreme Court Ruling, VK2735 Obesity Trial, and Padcev-Keytruda Survival Gains

Andy Studna, Senior Editor
Credit: photon_photo | stock.adobe.com. Clinical trial success depends on selecting appropriate clinical sites. Poor site selection can lead to delayed recruitment, compromised data quality, increased costs, and regulatory risks
August 28th 2025

Beyond Prediction: An Evidence-Based Framework for Assessing Site Selection Decisions

Anh Ninh, Linh Nguyen and Daniel Butler
ACT Brief Episode 5: How Digital Twins and AI Are Reshaping Clinical Trials
August 28th 2025

ACT Brief Episode 5: How Digital Twins and AI Are Reshaping Clinical Trials

Andy Studna, Senior Editor
Phase I/II RAINFOL-01 Trial Results Lead to FDA Breakthrough Designation for Genmab’s Rina-S for Advanced Endometrial Cancer
August 28th 2025

Phase I/II RAINFOL-01 Trial Results Lead to FDA Breakthrough Designation for Genmab’s Rina-S for Advanced Endometrial Cancer

Don Tracy, Associate Editor
© Shuo - © Shuo - stock.adobe.com
August 28th 2025

Bias Starts Early in Research. So Can AI.

Stavroula Ntoufa
© 2025 MJH Life Sciences

All rights reserved.